Fedin-20 Piroxicam 20mg 30 caps

FEDIN-20 Indications

Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis.
 

Because of the safety profile of piroxicam is not a first-choice, if shown the use of other nonsteroidal anti-inflammatory or anti-rheumatic drugs. The decision to appoint piroxicam should be based on an individual assessment of the overall risk to the patient.

Dosage and administration

The primary purpose piroxicam should be made a doctor with experience in diagnostic evaluation and treatment of patients with inflammatory or degenerative rheumatic diseases. The maximum recommended dose is 20 mg.
Side effects can be reduced by using the minimum effective dose for the shortest period of time necessary to control symptoms.

The benefits of treatment and tolerability of the drug should be reviewed every 14 days. If prolonged treatment is necessary, this reassessment should be conducted more frequently. Given the proven fact that the use of piroxicam is associated with an increased risk of gastrointestinal complications should carefully consider the need for combined treatment hastroprotektyvnymy agents (eg misoprostol or proton pump inhibitors), especially in elderly patients.

Adults should apply internally 1 capsule of 20 mg 1 time a day preferably during or immediately after a meal with water.
The duration of treatment depends on the disease and is determined by your doctor.
The total daily dose should not exceed 20 mg.

Children under 18 are not used because there is not enough clinical experience regarding the safe use of piroxicam this age category of patients.